Letermovir Patent Expiration
Letermovir was first introduced by Merck Sharp And Dohme Corp
Letermovir Patents
Given below is the list of patents protecting Letermovir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prevymis | US10603384 | Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative | Feb 28, 2033 | Merck Sharp Dohme |
| Prevymis | US7196086 | Substituted dihydroquinazolines |
May 22, 2024
(Expired) | Merck Sharp Dohme |
| Prevymis | US8513255 | Substituted dihydroquinazolines |
May 22, 2024
(Expired) | Merck Sharp Dohme |
| Prevymis | USRE46791 | Substituted dihydroquinazolines | Jan 18, 2029 | Merck Sharp Dohme |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳